Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

Medtronic Inc. recalls ICM LNQ22 LINQ II

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
It may create the potential for amplified noise and/or overall signal reduction of the ICM, which may interfere with intended recordings of heart rhythms. This noise pattern is different from occasional noise due to device position/migration, patient activity, or external electromagnetic interference.
Products
  • ICM LNQ22 LINQ II
Where it was sold

US and Australia, Austria, Belgium, Brunei Darussalam, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Iceland, Ireland, Israel, Italy, Japan, Liechtenstein, Luxembourg, Macao, Malaysia, Netherlands, New Zealand, Northern Ireland, Norway, Portugal, Puerto Rico, Saudi Arabia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, United Arab Emirates, United Kingdom

States: Puerto Rico

Barcodes
00763000060374007630000603810076300055399900763000554002007630006137470076300063511400763000871642
Units affected
64,739 units
About this recall
ICM LNQ22 LINQ II, Model LNQ22; Insertable Cardiac Monitor